FPP(RGD)2: Clinical Trials

1 trial of FPP(RGD)2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow FPP(RGD)2: new trials by email Literature Review of FPP(RGD)2 trials Research Report on FPP(RGD)2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedSanjiv Sam Gambhir252013-03-042019-10-03

Conditions studied

Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Colonic Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Sanjiv Sam Gambhir (1)

Countries

United States (1)

Top investigators

Sanjiv Gambhir, MD, PhD (1)

Results publications

PMID 25965900, PMID 26062933, PMID 26611425, PMID 30850872